HomeInsightsMarket Capitalization

Market Capitalization of Cipla Ltd

Market Capitalization of Cipla Ltd

stocks purchased

₹ 10.7 Cr

Volume transacted

stocks purchased

66.2 K

stocks traded

Last Updated time: 10 Oct 15:30 PM

Image

Cipla Ltd

NSE: CIPLA

MARKETCAP

130708.75 crore

Last updated: 10 Oct 24

Key Highlights

  • The Market Cap of Cipla Ltd is ₹ 130708 crore as of 10 Oct 24.
  • The Market Cap of Cipla Ltd changed from ₹ 42645 crore on March 2019 to ₹ 120673 crore on March 2024 . This represents a CAGR of 18.93% over 6 years. .
  • The Latest Trading Price of Cipla Ltd is ₹ 1618 as of 10 Oct 15:30.

Historical Market Cap of Cipla Ltd

No data available

* All values are in crore

Company Fundamentals for Cipla Ltd

No data available

Image

Cipla Ltd

NSE: CIPLA

PRICE

1618.55

-62.50 (-3.72%)

stock direction

Last updated: 10 Oct 15:30

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Cipla Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
10 Oct 20241618.55
09 Oct 20241681.05
08 Oct 20241640.6
07 Oct 20241624.7
04 Oct 20241622.85
03 Oct 20241656
01 Oct 20241663.55
30 Sep 20241654
27 Sep 20241671.6
26 Sep 20241622.1

SWOT Analysis Of Cipla Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Cipla Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Cipla Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Cipla Ltd301,35,756
Sun Pharmaceuticals Industries Ltd434,63,360
Divis Laboratories Ltd941,58,943
Torrent Pharmaceuticals Ltd721,20,439
Dr Reddys Laboratories Ltd201,11,289
Mankind Pharma Ltd541,07,653

Key Valuation Metric of Cipla Ltd

No data available

Historical P/E Ratio of Cipla Ltd

No data available

* All values are in %

Historical Revenue of Cipla Ltd

No data available

* All values are in crore

Historical EBITDA of Cipla Ltd

No data available

* All values are in crore

Historical Net Profit of Cipla Ltd

No data available

* All values are in crore

Historical Dividend Payout of Cipla Ltd

No data available

* All values are in %

About Cipla Ltd

  • Cipla Ltd is one of the leading pharmaceutical companies in India.
  • The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).
  • Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments.
  • With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets.
  • Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories. Cipla Ltd was incorporated in the year 1935 with the name Chemical, Industrial & Pharmaceutical Laboratories Ltd.

Cipla Ltd News Hub

News

Cipla Ltd gains for third straight session

Cipla Ltd is up for a third straight session today. The stock is quoting at Rs 1666.4, up ...

Read more

09 Oct 202413:05

News

Cipla to table results

Cipla will hold a meeting of the Board of Directors of the Company on 29 October 2024. Pow...

Read more

03 Oct 202410:15

News

Cipla's UK arm inks pact to acquire 6.9124% stake in Cipla Jiangsu Pharmaceuticals

Cipla Jiangsu was incorporated in China on 8th August 2019 as a joint venture between Cipl...

Read more

26 Sep 202410:27

News

Cipla to acquire JV partners' 6.91% in Cipla Jiangsu

Cipla announced that its wholly owned subsidiary in UK, Cipla (EU) has entered into a defi...

Read more

25 Sep 202417:38

News

Cipla Ltd up for third consecutive session

Cipla Ltd is up for a third straight session today. The stock is quoting at Rs 1650.9, up ...

Read more

11 Sep 202413:06

News

Cipla vice-chairman M.K. Hamied resigns

Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex ...

Read more

04 Sep 202408:56

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Cipla Ltd

What is the market cap of Cipla Ltd?

As of October 10, 2024, Cipla Ltd has a market capitalization of ₹130708.75, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Cipla Ltd's market capitalization?

Cipla Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Cipla Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Cipla Ltd's market capitalization change?

Cipla Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*